Catalyst Wire Dossier Catalyst Wire Dossier

Visudyne

verteporfin · Novartis
Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for Visudyne, covering 2007-01-15 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study [Phase 2]

See pricing